Anaemia and prognosis in acute coronary syndromes: A systematic review and meta-analysis

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 43-55

  Liu, Y ^a   Yang, Y M ^a   Zhu, J ^a   Tan, H Q ^a   Liang, Y ^a   Li, J D ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Anaemia; Meta analysis; Mortality; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANEMIA; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84863290162     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000105     Document Type: Article

References (37)

1. Groenveld HF, Januzzi JL, Damman K, et al: Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52: 818-827.
2. DeFoe GR, Ross CS, Olmstead EM, et al: Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71: 769-776.
3. Willis P, Voeltz MD: Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol 2009; 104(5 suppl): 34C-38C.
4. Wu WC, Rathore SS, Wang Y, et al: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-1236.
5. Nikolsky E, Aymong ED, Halkin A, et al: Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-553.
6. Lipsic E, van der Horst IC, Voors AA, et al: Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol 2005; 100: 289-292.
7. Dauerman HL, Lessard D, Yarzebski J, et al: Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 2005; 96: 1379-1383.
8. Sabatine MS, Morrow DA, Giugliano RP, et al: Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049.
9. Shu DH, Ransom TP, O'Connell CM, et al: Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovasc Diabetol 2006; 5: 8.
10. Archbold RA, Balami D, Al-Hajiri A, et al: Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J 2006; 152: 1091-1095.
11. Alexander KP, Chen AY, Wang TY, et al: Transfusion practice and outcomes in non-STsegment elevation acute coronary syndromes. Am Heart J 2008; 155: 1047-1053.
12. Vaglio J, Safley DM, Rahman M, et al: Relation of anemia at discharge to survival after acute coronary syndromes. Am J Cardiol 2005; 96: 496-499.
13. Most AS, Ruocco NA Jr, Gewirtz H: Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 1986; 74: 1085-1092.
14. Levy PS, Quigley RL, Gould SA: Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 1996; 41: 416-423.
15. Al Falluji N, Lawrence-Nelson J, Kostis JB, et al: Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144: 636-641.
16. Stroup DF, Berlin JA, Morton SC, et al: Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
17. Harris RP, Helfand M, Woolf SH, et al: Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20(3 suppl): 21-35.
18. Altman DG: Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-228.
19. González-Ferrer JJ, García-Rubira JC, Balcones DV, et al: Influence of hemoglobin level on inhospital prognosis in patients with acute coronary syndrome. Rev Esp Cardiol 2008; 61: 945-952 [in English and Spanish].
20. Kruk M, Przyłuski J, Kalińczuk L, et al: Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: ANIN Myocardial Infarction Registry. Circ J 2009; 73: 323-329.
21. Meneveau N, Schiele F, Seronde MF, et al: Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 2009; 103: 442-447.
22. Manoukian SV, Feit F, Mehran R, et al: Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007; 49: 1362-1368.
23. Langston RD, Presley R, Flanders WD, et al: Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 2003; 64: 1398-1405.
24. Aronson D, Suleiman M, Agmon Y, et al: Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 2007; 28: 1289-1296.
25. Valeur N, Nielsen OW, McMurray JJ: Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail 2006; 8: 577-584.
26. Anker SD, Voors A, Okonko D, et al: Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009; 30: 1331-1339.
27. Kurek T, Lenarczyk R, Kowalczyk J, et al: Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2010; 105: 611-618.
28. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
29. Maroko PR, Braunwald E: Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. Circulation 1976; 53(3 suppl): I162-I168.
30. Levy PS, Kim SJ, Eckel PK, et al: Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol 1993; 265: H340-H349.
31. Mak KH, Moliterno DJ, Granger CB, et al: Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 171-179.
32. Anderson RD, White HD, Ohman EM, et al: Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global use of strategies to open occluded coronary arteries. Am Heart J 2002; 144: 81-88.
33. Best PJ, Lennon R, Ting HH, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119.
34. Tahnk-Johnson ME, Sharkey SW: Impact of thrombolytic therapy on hemoglobin change after acute myocardial infarction. Am J Cardiol 1993; 71: 869-872.
35. Nikolsky E, Mehran R, Dangas G, et al: Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007; 28: 1936-1945.
36. Moscucci M, Fox KA, Cannon CP, et al: Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
37. Feit F, Voeltz MD, Attubato MJ, et al: Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007; 100: 1364-1369.